A retrospective review of α-gal syndrome complicating the management of suspected pancreatic exocrine insufficiency in one gastroenterology clinic in central Virginia

The galactose-α-1,3-galactose (α-gal) mammalian meat allergy, α-gal syndrome, often includes diarrhea, abdominal pain, and other gastrointestinal (GI) symptoms. Pancreatic exocrine insufficiency causes similar symptoms. The pancreatic replacement enzymes, referred to here as pancreatic enzymes, used...

Full description

Bibliographic Details
Main Authors: Nathan E. Richards, Jeffrey M. Wilson, Thomas A. E. Platts-Mills, Robert D. Richards
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Gastroenterology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgstr.2023.1162109/full
_version_ 1797772012055166976
author Nathan E. Richards
Jeffrey M. Wilson
Thomas A. E. Platts-Mills
Robert D. Richards
author_facet Nathan E. Richards
Jeffrey M. Wilson
Thomas A. E. Platts-Mills
Robert D. Richards
author_sort Nathan E. Richards
collection DOAJ
description The galactose-α-1,3-galactose (α-gal) mammalian meat allergy, α-gal syndrome, often includes diarrhea, abdominal pain, and other gastrointestinal (GI) symptoms. Pancreatic exocrine insufficiency causes similar symptoms. The pancreatic replacement enzymes, referred to here as pancreatic enzymes, used to treat pancreatic insufficiency are porcine products and contain α-gal. Patients with pancreatic insufficiency who also have α-gal syndrome may be intolerant of mammalian products in their diet and of α-gal in pancreatic enzymes. In this article, we describe 40 patients from one GI clinic in central Virginia with suspected pancreatic insufficiency and increased α-gal immunoglobulin E (IgE) levels. Over 50% of these patients had some clinical improvement when mammalian products were removed from the diet. Most patients could tolerate pancreatic enzymes; 10% could not tolerate them due to suspected allergy symptoms, but none developed anaphylaxis. Understanding that α-gal syndrome can be superimposed on pancreatic exocrine insufficiency and exacerbate symptoms, and that treatment with pancreatic enzymes may increase GI and/or allergy symptoms in this group, will lead to improved medical management of this complex patient population.
first_indexed 2024-03-12T21:45:54Z
format Article
id doaj.art-07850f0887344908b6c505da31e7231e
institution Directory Open Access Journal
issn 2813-1169
language English
last_indexed 2024-03-12T21:45:54Z
publishDate 2023-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Gastroenterology
spelling doaj.art-07850f0887344908b6c505da31e7231e2023-07-26T11:59:44ZengFrontiers Media S.A.Frontiers in Gastroenterology2813-11692023-07-01210.3389/fgstr.2023.11621091162109A retrospective review of α-gal syndrome complicating the management of suspected pancreatic exocrine insufficiency in one gastroenterology clinic in central VirginiaNathan E. Richards0Jeffrey M. Wilson1Thomas A. E. Platts-Mills2Robert D. Richards3Division of Allergy and Clinical Immunology, University of Virginia, Charlottesville, VA, United StatesDivision of Allergy and Clinical Immunology, University of Virginia, Charlottesville, VA, United StatesDivision of Allergy and Clinical Immunology, University of Virginia, Charlottesville, VA, United StatesGastroenterology Associates of Central Virginia, Lynchburg, VA, United StatesThe galactose-α-1,3-galactose (α-gal) mammalian meat allergy, α-gal syndrome, often includes diarrhea, abdominal pain, and other gastrointestinal (GI) symptoms. Pancreatic exocrine insufficiency causes similar symptoms. The pancreatic replacement enzymes, referred to here as pancreatic enzymes, used to treat pancreatic insufficiency are porcine products and contain α-gal. Patients with pancreatic insufficiency who also have α-gal syndrome may be intolerant of mammalian products in their diet and of α-gal in pancreatic enzymes. In this article, we describe 40 patients from one GI clinic in central Virginia with suspected pancreatic insufficiency and increased α-gal immunoglobulin E (IgE) levels. Over 50% of these patients had some clinical improvement when mammalian products were removed from the diet. Most patients could tolerate pancreatic enzymes; 10% could not tolerate them due to suspected allergy symptoms, but none developed anaphylaxis. Understanding that α-gal syndrome can be superimposed on pancreatic exocrine insufficiency and exacerbate symptoms, and that treatment with pancreatic enzymes may increase GI and/or allergy symptoms in this group, will lead to improved medical management of this complex patient population.https://www.frontiersin.org/articles/10.3389/fgstr.2023.1162109/fullα-galα-gal syndromepancreatic exocrine insufficiencypancreatic enzyme replacementIgEGI-variant α-gal syndrome
spellingShingle Nathan E. Richards
Jeffrey M. Wilson
Thomas A. E. Platts-Mills
Robert D. Richards
A retrospective review of α-gal syndrome complicating the management of suspected pancreatic exocrine insufficiency in one gastroenterology clinic in central Virginia
Frontiers in Gastroenterology
α-gal
α-gal syndrome
pancreatic exocrine insufficiency
pancreatic enzyme replacement
IgE
GI-variant α-gal syndrome
title A retrospective review of α-gal syndrome complicating the management of suspected pancreatic exocrine insufficiency in one gastroenterology clinic in central Virginia
title_full A retrospective review of α-gal syndrome complicating the management of suspected pancreatic exocrine insufficiency in one gastroenterology clinic in central Virginia
title_fullStr A retrospective review of α-gal syndrome complicating the management of suspected pancreatic exocrine insufficiency in one gastroenterology clinic in central Virginia
title_full_unstemmed A retrospective review of α-gal syndrome complicating the management of suspected pancreatic exocrine insufficiency in one gastroenterology clinic in central Virginia
title_short A retrospective review of α-gal syndrome complicating the management of suspected pancreatic exocrine insufficiency in one gastroenterology clinic in central Virginia
title_sort retrospective review of α gal syndrome complicating the management of suspected pancreatic exocrine insufficiency in one gastroenterology clinic in central virginia
topic α-gal
α-gal syndrome
pancreatic exocrine insufficiency
pancreatic enzyme replacement
IgE
GI-variant α-gal syndrome
url https://www.frontiersin.org/articles/10.3389/fgstr.2023.1162109/full
work_keys_str_mv AT nathanerichards aretrospectivereviewofagalsyndromecomplicatingthemanagementofsuspectedpancreaticexocrineinsufficiencyinonegastroenterologyclinicincentralvirginia
AT jeffreymwilson aretrospectivereviewofagalsyndromecomplicatingthemanagementofsuspectedpancreaticexocrineinsufficiencyinonegastroenterologyclinicincentralvirginia
AT thomasaeplattsmills aretrospectivereviewofagalsyndromecomplicatingthemanagementofsuspectedpancreaticexocrineinsufficiencyinonegastroenterologyclinicincentralvirginia
AT robertdrichards aretrospectivereviewofagalsyndromecomplicatingthemanagementofsuspectedpancreaticexocrineinsufficiencyinonegastroenterologyclinicincentralvirginia
AT nathanerichards retrospectivereviewofagalsyndromecomplicatingthemanagementofsuspectedpancreaticexocrineinsufficiencyinonegastroenterologyclinicincentralvirginia
AT jeffreymwilson retrospectivereviewofagalsyndromecomplicatingthemanagementofsuspectedpancreaticexocrineinsufficiencyinonegastroenterologyclinicincentralvirginia
AT thomasaeplattsmills retrospectivereviewofagalsyndromecomplicatingthemanagementofsuspectedpancreaticexocrineinsufficiencyinonegastroenterologyclinicincentralvirginia
AT robertdrichards retrospectivereviewofagalsyndromecomplicatingthemanagementofsuspectedpancreaticexocrineinsufficiencyinonegastroenterologyclinicincentralvirginia